Register for email alerts and news feeds:
This journal | BMJ Group
rss
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
A Lanas, L A García-Rodríguez, M T Arroyo, F Gomollón, F Feu, A González-Pérez, E Zapata, G Bástida, L Rodrigo, S Santolaria, M Güell, C M de Argila, E Quintero, F Borda, J M Piqué, and on behalf of the Investigators of the Asociación Española de Gastroenterología (AEG)
Gut 2006 55: 1731-1738.

Competing interests: AL has received fees for speaking, research or travel support from AstraZeneca, Merck Sharp & Dhome, Pfizer, Almirall Prodesfarma and TAP. LAG-R has received fees for speaking from Merck Sharp & Dhome, Pfizer and AstraZeneca, and research grants from Pfizer and AstraZeneca. FG, EQ, LR and JMP have received fees for speaking and research grants or travel support from AstraZeneca, Merck, Pfizer and Almirall Prodesfarma. The other authors have not reported conflict of interest.

This Article

Services

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs